VYNE Therapeutics (VYNE) and Ardelyx (ARDX) Top Cantor Fitzgerald's Most Shorted Biotech List Dec 28, 2021 05:55AM
Aridis' (ARDS) Omicron Data is Positive, Reiterates Belief that Pipeline is Undervalued - Cantor Fitzgerald Dec 21, 2021 11:44AM
Aridis Pharmaceuticals to Host Fireside Chat with Analysts to Discuss 2021 Outlook for its Lead Programs and Novel mAb Discovery Platform on December 4th, 2020 Nov 24, 2020 05:30AM
Aridis Pharmaceuticals Announces Third Quarter 2020 Results Nov 20, 2020 04:05PM
Aridis Pharmaceuticals to Present at Upcoming Investor Conferences Sep 4, 2020 01:32PM


Aug 11, 2020 04:05PM Aridis Pharmaceuticals Announces Second Quarter 2020 Results
Jun 26, 2020 05:30AM Aridis Pharmaceuticals to Participate in Cantor Fitzgerald Virtual Symposium: Winning Ways to Treat Infections and COVID-19
Jun 18, 2020 05:30AM Aridis Pharmaceuticals to Discuss APEX™ in Virtual Fireside Chat Hosted by Cantor Fitzgerald on June 25th
Jun 17, 2020 06:57AM Companies with NDRs 6/17
Jun 16, 2020 07:04AM Companies with NDRs 6/16
Mar 4, 2020 05:30AM Aridis Pharmaceuticals Provides Update on Investor Day Featuring Key Opinion Leader Panels on Cystic Fibrosis and Pneumonia
Feb 18, 2020 05:30AM Aridis Pharmaceuticals to Host Investor Day Showcasing APEX™ Technology Platform and Key Opinion Leader Panels on Cystic Fibrosis and Pneumonia
Jan 27, 2020 01:38PM Aridis Pharmaceuticals (ARDS) Highlighted at Cantor Fitzgerald on Coronavirus Opportunity
Dec 27, 2018 06:43AM Cantor Highlights Aridis Pharmaceuticals Inc. (ARDS) Ahead Of Data Readouts In 2019
Sep 10, 2018 05:06AM Cantor Fitzgerald Starts Aridis Pharmaceuticals (ARDS) at Overweight
Aug 14, 2018 05:52AM Aridis Pharmaceuticals Inc. (ARDS) Prices 2M Share IPO at $13/Sh
Aug 13, 2018 07:31PM Aridis Pharmaceuticals Announces Pricing of Initial Public Offering